1549-4918/asset/cover.gif?v=1&s=51ac62b4272cd760b70f0cb1539035cc40743da6 "STEM CELLS")
Telephone: 508-791-0305 extension 684, Fax: 508-756-4468
1549-4918/asset/olbannerleft.jpg?v=1&s=699114e871887e6b838f6a1c657fe256cfe127a6)
1549-4918/asset/olbannerright.gif?v=1&s=603f8f2ab5cd9d4f783c231915608956af51aeea)
Embryonic Stem Cells/Induced Pluripotent Stem Cells
You have free access to this content
Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence†‡§
Article first published online: 12 FEB 2010
DOI: 10.1002/stem.321
Copyright © 2010 AlphaMed Press
Additional Information
How to Cite
Feng, Q., Lu, S.-J., Klimanskaya, I., Gomes, I., Kim, D., Chung, Y., Honig, G. R., Kim, K.-S. and Lanza, R. (2010), Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence. STEM CELLS, 28: 704–712. doi: 10.1002/stem.321
- †
Author contributions: Q.F.: Conception and design, collection and assembly of data, data analysis and interpretation, manuscript writing; S-J.L.: Conception and design, collection and assembly of data, data analysis and interpretation, manuscript writing, and final approval of manuscript; I.K., I.G., D.K., Y.C.: Collection and assembly of data; G.H.: Data analysis and interpretation; K-S.K.: Collection and assembly of data, data analysis and interpretation; R.L.: Conception and design, data analysis and interpretation, manuscript writing, and final approval of manuscript.
- ‡
First published online in STEM CELLS EXPRESS February 4, 2010.
- §
Disclosure of potential conflicts of interest is found at the end of this article.
- ¶
Telephone: 508-791-0305 extension 684, Fax: 508-756-4468
- ‖
Telephone: 508-756-1212 extension 655, Fax: 508-756-4468
Publication History
- Issue published online: 14 APR 2010
- Article first published online: 12 FEB 2010
- Manuscript Accepted: 4 FEB 2010
- Manuscript Received: 15 DEC 2009
References
- 1, , et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917–1920.
- 2, , et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861–872.
- 3, , et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458: 766–770.
- 4, , et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458: 771–775.
- 5, , et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797–801.
- 6, , et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4: 472–476.
- 7, , et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4: 381–384.
- 8, , et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009; 104: e30–e41.
- 9, , et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 2009; 19: 429–438.
- 10, , et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009; 19: 1233–1242.
- 11, , et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A 2009; 106: 16698–16703.
- 12, , et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009; 27: 2427–2434.
- 13, , et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009; 458: 126–131.
- 14, , et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 2009; 122: 3169–3179.
- 15, , et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218–1221.
- 16, , et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136: 964–977.
- 17, , et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009; 27: 559–567.
- 18, , . Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. J Clin Invest 2009; 119: 2818–2829.
- 19, , et al. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009; 114: 5473–5480.
- 20, , et al. Hematopoietic development from human induced pluripotent stem cells. Ann N Y Acad Sci 2009; 1176: 219–227.
- 21, , et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 2007; 4: 501–509.
- 22, , et al. Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regen Med 2008; 3: 693–704.
- 23, , et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008; 112: 4475–4484.
- 24, , et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145–1147.
- 25, , et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 2004; 350: 1353–1356.
- 26, , et al. Human embryonic stem-cell lines derived from single blastomeres. Nature 2006; 444: 481–485.
- 27, , et al. Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell 2008; 2: 113–117.
- 28
- 29, , et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349–352.
- 30, , et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004; 6: 217–245.
- 31, . Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008; 132: 661–680.
- 32, , et al. Induction and isolation of vascular cells from human induced pluripotent stem cells–brief report. Arterioscler Thromb Vasc Biol 2009; 29: 1100–1103.
- 33, , et al. Adipogenic differentiation of human induced pluripotent stem cells: Comparison with that of human embryonic stem cells. FEBS Lett 2009; 583: 1029–1033.
- 34, , et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5: 111–123.
- 35, , et al. Clone and gene specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 2009; 27: 2686–2690.
- 36, , et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009; 41: 1350–1353.
- 37, , et al. Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical response against colon cancer. Stem Cells 2009; 27: 3103–3111.
- 38, , et al. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009; 5: 135–138.
- 39, , et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009; 461: 86–90.
- 40, , et al. Adult mice generated from induced pluripotent stem cells. Nature 2009; 461: 91–94.
- 41, , et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007; 318: 1920–1923.
- 42, , et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009; 460: 1132–1135.
- 43, , et al. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 2009; 460: 909–913.
- 44, , et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009; 41: 843–848.